*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
In Q120, the US Surgical Matrices Market grew +1.6% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan* maintained its lead despite the slowdown in breast augmentation and reconstruction surgeries due to COVID-19, gaining +3.4% YoY. Becton Dickinson* (BD) also had been growing well until COVID-19 slowed hernia surgeries, and, like many other companies, warned that Q220 would be far worse since the impact of COVID-19 would be felt at the beginning of the quarter.
Among the many topics covered in the comprehensive Q120 US Surgical Matrices Market Recap* are:
The US Surgical Matrices market grew modestly in both the Breast Reconstruction and Hernia Repair segments, with both segments experiencing good growth until surgeries began to be delayed in mid- to late March due to the impact of COVID-19. For the quarter, the Breast segment managed to grow +2.4% YoY to $
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.